Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study

Published:2017-09-07 Issue: Volume: Page:j3837
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Mostaghim Sana R,Gagne Joshua J,Kesselheim Aaron S^ORCID

Publisher

BMJ

Subject

General Engineering

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA Labeling;Drug Safety;2024-07-31

2. Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals;Clinical and Translational Science;2024-07

3. Association between expedited review designations and the US or global burden of disease for drugs approved by the US Food and Drug Administration, 2010–2019: a cross-sectional analysis;BMJ Open;2024-03

4. The Dawn of In Vivo Gene Editing Era: A Revolution in the Making;Biologics;2023-09-25

5. Complicated regulatory decision-making following inconsistent trial results: the issue with ibrutinib for mantle cell lymphoma;Nature Reviews Clinical Oncology;2023-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP